About
Benjamin Swerner is a co-founder and Chief Operating Officer of Relation Therapeutics, a London-based techbio company developing an AI-enabled drug discovery platform. Relation’s site says he leads operational, corporate development, and strategy work, and previously worked at DN Capital focusing on healthcare and deep-tech investing. SEC and trade-press sources also identify him as an executive officer and co-founder of Relation.
Areas of interest
biotechdrug discoveryAImachine learninghealthcaredeep techtechbio